The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro
Abstract
Objective: Osteoarthritic (OA) cartilage destruction depends on collagen‐ and aggrecan‐degrading proteases such as collagenases (MMP‐1 and MMP‐13), stromelysin (MMP‐3), MMP‐14, as well as the so‐called aggrecanases (ADAM‐TS4 and ADAM‐TS5). In this study, we tried to clarify whether these proteases are expressed in vivo in human normal and OA cartilage (and whether they are up‐regulated or down‐regulated during the disease process) and in interleukin‐1β (IL‐1β)–stimulated chondrocytes in vitro. Methods: Quantitative polymerase chain reaction assays were developed and performed on RNA isolated directly from normal and degenerative cartilage tissue as well as from primary human articular chondrocytes cultured with and without IL‐1β. Results: In vivo, MMP‐1 was detectable only at very low levels in any condition. MMP‐13 expression was low in normal and early degenerative cartilage but was strongly up‐regulated in late‐stage OA specimens. MMP‐1 and MMP‐13 were expressed much higher in vitro than in vivo and were up‐regulated by IL‐1β. Among all proteases, MMP‐3 was by far the most strongly expressed, although it was strongly down‐regulated in late‐stage OA specimens. Expression of MMP‐3 was higher in vitro than in vivo and was up‐regulated by IL‐1β. ADAM‐TS5 and MMP‐14 were expressed in all sample groups. Expression of ADAM‐TS4 was very low in vivo and was induced in vitro after stimulation by IL‐1β. Conclusion: Our expression data clearly support MMP‐13 as the major collagenase in OA cartilage. The most strongly expressed aggrecanase was ADAM‐TS5. ADAM‐TS4 was expressed only at a very low level in normal cartilage and was only slightly up‐regulated in OA cartilage, casting doubt on this enzyme being the relevant aggrecanase of articular cartilage. Results of our study show that expression of many enzymes is significantly different in vitro and in vivo and suggest that IL‐1β stimulation of articular chondrocytes might not be a good model for the matrix catabolism in OA cartilage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MANKIN, H. J., DORFMAN, H., LIPPIELLO, L., & ZARINS, A. (1971) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-197153030-00009 · Cited by 1,963
Charalambous, C. P. (2014) · Classic Papers in Orthopaedics · doi:10.1007/978-1-4471-5451-8_97 · Cited by 1,835
Matrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
Billinghurst, R. C., Dahlberg, L., Ionescu, M., Reiner, A., Bourne, R., Rorabeck, C., Mitchell, P., Hambor, J., Diekmann, O., Tschesche, H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119316 · Cited by 968
Mitchell, P. G., Magna, H. A., Reeves, L. M., Lopresti-Morrow, L. L., Yocum, S. A., Rosner, P. J., Geoghegan, K. F., & Hambor, J. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118475 · Cited by 940
Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., & Okada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2446 · Cited by 938
Biochemical Characterization of Human Collagenase-3
Knäuper, V., López-Otin, C., Smith, B., Knight, G., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1544 · Cited by 881
Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation
Knäuper, V., Will, H., López-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17124 · Cited by 747
Balance between swelling pressure and collagen tension in normal and degenerate cartilage
MAROUDAS, A. (1976) · Nature · doi:10.1038/260808a0 · Cited by 726
Purification and Cloning of Aggrecanase-1: A Member of the ADAMTS Family of Proteins
Tortorella, M. D., Burn, T. C., Pratta, M. A., Abbaszade, I., Hollis, J. M., Liu, R., Rosenfeld, S. A., Copeland, R. A., Decicco, C. P., Wynn, R., et al. (1999) · Science · doi:10.1126/science.284.5420.1664 · Cited by 686
Cited by
Goldring, M. B., & Goldring, S. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21258 · Cited by 1,179
“Genomic and proteomic analyses of global gene expression in cartilage have confirmed the increased levels of type II collagen (COL2A1) mRNA levels in early OA cartilage (Bau et al., 2002; Hermansson et al., 2004; Aigner et al., 2006).”
BackgroundADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
Stanton, H., Rogerson, F. M., East, C. J., Golub, S. B., Lawlor, K. E., Meeker, C. T., Little, C. B., Last, K., Farmer, P. J., Campbell, I. K., et al. (2005) · Nature · doi:10.1038/nature03417 · Cited by 915
Cartilage homeostasis in health and rheumatic diseases
Goldring, M. B., & Marcu, K. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2592 · Cited by 762
Little, C. B., Barai, A., Burkhardt, D., Smith, S. M., Fosang, A. J., Werb, Z., Shah, M., & Thompson, E. W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25002 · Cited by 642
Proteases involved in cartilage matrix degradation in osteoarthritis
Troeberg, L., & Nagase, H. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.06.020 · Cited by 579
Bondeson, J., Wainwright, S. D., Lauder, S., Amos, N., & Hughes, C. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2099 · Cited by 527
Miyaki, S., Nakasa, T., Otsuki, S., Grogan, S. P., Higashiyama, R., Inoue, A., Kato, Y., Sato, T., Lotz, M. K., & Asahara, H. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24745 · Cited by 496
535 East 70th Street, C. R. B., Goldring, M., Otero, M., Plumb, D., Dragomir, C., Favero, M., EI Hachem, K., Hashimoto, K., Roach, H., Olivotto, E., et al. (2011) · European Cells and Materials · doi:10.22203/ecm.v021a16 · Cited by 489
Oxygen and reactive oxygen species in cartilage degradation: friends or foes?
Henrotin, Y., Kurz, B., & Aigner, T. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.04.002 · Cited by 487
Self-citationAltered Proteolytic Activities of ADAMTS-4 Expressed by C-terminal Processing
Kashiwagi, M., Enghild, J. J., Gendron, C., Hughes, C., Caterson, B., Itoh, Y., & Nagase, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312123200 · Cited by 409
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5
Song, R., D. Tortorella, M., Malfait, A., Alston, J. T., Yang, Z., Arner, E. C., & Griggs, D. W. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22334 · Cited by 405
Expression profiling of metalloproteinases and their inhibitors in cartilage
Kevorkian, L., Young, D. A., Darrah, C., Donell, S. T., Shepstone, L., Porter, S., Brockbank, S. M. V., Edwards, D. R., Parker, A. E., & Clark, I. M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11433 · Cited by 404
Aigner, T., Fundel, K., Saas, J., Gebhard, P. M., Haag, J., Weiss, T., Zien, A., Obermayr, F., Zimmer, R., & Bartnik, E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22174 · Cited by 352
Self-citationRoach, H. I., Yamada, N., Cheung, K. S. C., Tilley, S., Clarke, N. M. P., Oreffo, R. O. C., Kokubun, S., & Bronner, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21300 · Cited by 351
Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage
Wang, X., Manner, P. A., Horner, A., Shum, L., Tuan, R. S., & Nuckolls, G. H. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.08.008 · Cited by 311
Characterization of and osteoarthritis susceptibility in ADAMTS‐4–knockout mice
Glasson, S. S., Askew, R., Sheppard, B., Carito, B. A., Blanchet, T., Ma, H., Flannery, C. R., Kanki, K., Wang, E., Peluso, D., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20558 · Cited by 281
Simopoulou, T., Malizos, K. N., Iliopoulos, D., Stefanou, N., Papatheodorou, L., Ioannou, M., & Tsezou, A. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.01.018 · Cited by 275
Aigner, T. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.009 · Cited by 272
Self-citationAigner, T., Söder, S., Gebhard, P. M., McAlinden, A., & Haag, J. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0534 · Cited by 269
Self-citationTumor Necrosis Factorα Modulates Matrix Production and Catabolism in Nucleus Pulposus Tissue
Séguin, C. A., Pilliar, R. M., Roughley, P. J., & Kandel, R. A. (2005) · Spine · doi:10.1097/01.brs.0000176188.40263.f9 · Cited by 265
Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism
Goldring, M. B., Otero, M., Tsuchimochi, K., Ijiri, K., & Li, Y. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098764 · Cited by 262
Brew, C. J., Clegg, P. D., Boot-Handford, R. P., Andrew, J. G., & Hardingham, T. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.097139 · Cited by 134
Zhang, X., Xu, X., Xu, T., & Qin, S. (2014) · Drug Development Research · doi:10.1002/ddr.21170 · Cited by 83
Dunn, S. L., Wilkinson, J. M., Crawford, A., Le Maitre, C. L., & Bunning, R. A. D. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.10.016 · Cited by 46
Metadata
- Authors
- Bau, B., Gebhard, P. M., Haag, J., Knorr, T., Bartnik, E., & Aigner, T.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-10
- Volume
- 46
- Issue
- 10
- Pages
- 2648-2657
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1990844960
- Cited by
- 385
- References
- 47
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.